Christina Applegate Investigates Breast Implants as Pain Mystery Deepens

Date:

Christina Applegate, 54, is investigating a potential connection between her breast implants and her ongoing pain and fatigue, following a misdiagnosis of multiple sclerosis (MS) that she received in 2021.

During the November 10 episode of her podcast MeSsy, co-hosted with actor Jamie-Lynn Sigler, Applegate, who rose to fame as a teen on the popular sitcom Married With Children, shared that she received a study indicating that symptoms linked to breast implants can mimic those of MS.

“I have been wondering for the past five years or so, ‘What if they are leaking and poisoning me?'” she remarked, expressing her intention to talk to her doctors about this possibility.

In 2008, Applegate underwent a double mastectomy and reconstruction after being diagnosed with an early stage of breast cancer and testing positive for a BRCA1 gene mutation, which increases the risk for breast and other cancers. On her podcast, she mentioned that she is “way overdue” for replacing her implants.

She has also reported experiencing increasing pain and trouble moving her right shoulder, stating it can take her at least 10 minutes to sit up and get out of bed. These symptoms feel overwhelming to her because “there’s so many different things that could be going on.”

Her investigation follows an announcement from doctors in October confirming she does not have MS. At that time, Applegate expressed that the news put her back at “Square 1,” as her physical challenges persist and she is undergoing evaluations for alternative explanations, including rheumatoid arthritis, lupus, and Lyme disease.

Although the origin of Applegate’s symptoms remains unclear, some instances of illness have been linked to breast implants, albeit the condition is not fully understood.

Understanding breast implant illness

As connections between breast implants and autoimmune diseases become clearer, women with breast implant illness urge doctors to warn others of the risks. Unknown hands hold a Biocell textured breast implant by Allergan.

Breast implant illness, or BII, refers to symptoms reported by certain individuals with implants, such as fatigue, cognitive changes, joint pain, and muscle discomfort. This image features a Biocell textured breast implant by Allergan. (Nicolas Amaya/CBC)

Breast implant illness, abbreviated as BII, encompasses symptoms reported by some individuals who have implants.

As of December 31, 2025, Health Canada had received 663 reports of symptoms or illnesses linked to breast implants, which translates to about one report for every 1,025 implants sold in Canada.

Fatigue was the most commonly reported issue, followed by mood changes, gastrointestinal problems, and cognitive alterations. It is important to note that these are reports, not confirmed cases; Health Canada indicates that the available data does not ascertain whether implants are the cause of these symptoms, as other factors may be involved.

The U.S. Food and Drug Administration (FDA) states that BII is not recognized as a formal medical diagnosis and lacks a specific test. Reports of symptoms like fatigue and joint pain do not indicate how frequently they occur or whether they are caused by implants.

Julie Elliott, a Canadian advocate for breast implant illness and implant-associated cancer, who claims to have faced health issues following breast augmentation, told CBC News that several symptoms reported by those with implants overlap with MS symptoms.

“Chronic fatigue, memory changes, concentration issues, numbness, tingling, nerve pain, muscle weakness, and hair loss — these symptoms are indeed similar to those of MS,” Elliott stated.

However, she advised caution against attributing Applegate’s symptoms to her implants. “I’m not suggesting that Christina Applegate’s breast implants are the source of her issues,” she added, stressing that it would be “premature and irresponsible” to make such assumptions.

“Similar symptoms do not inherently imply the same diagnosis,” Elliott remarked. “Nothing should be dismissed or ruled out without a thorough medical examination.”

A woman in a large black dress and carrying a black cane, poses on a red carpet.

Christina Applegate, left, attends the 29th Screen Actors Guild Awards in Century City, California, on February 26, 2023. (Valerie Macon/AFP/Getty Images)

Dr. Stephen Nicolaidis, a plastic surgeon from Montreal who has consulted with over 1,500 patients regarding implant removal, also highlighted the importance of exploring other potential causes.

He characterized BII as a “diagnosis of exclusion,” emphasizing that patients must undergo comprehensive evaluations, and if no other causes are found, the possibility that implants could be exacerbating the issues should be considered.

Nicolaidis noted that commonly reported symptoms include fatigue, hair loss, skin rashes, breathing difficulties, joint and muscle pain, sleep disturbances, and cognitive fog. Some of these can overlap with symptoms of autoimmune disorders.

Referring to the symptoms Applegate has publicly mentioned, he stated, “The symptoms she described can indeed be linked to her breast implants.” However, the exact cause of BII is not established, and he noted that researchers have not yet determined how implants might contribute to these symptoms.

Nicolaidis also pointed out that there is no specific diagnostic test for BII. Imaging can sometimes reveal silicone leakage from an implant, but such findings are not necessary for patients to report symptoms. He further noted that BII is distinct from implant-associated lymphoma, a cancer connected with certain textured implants.

Concerns about rupture, removal, and next steps

Ruptures or leaks are separate issues from BII. The FDA identifies rupture and deflation as potential complications of implants and recommends that patients consult a healthcare provider regarding any new or unusual changes in their breasts.

Similarly, Health Canada advises individuals with implants to regularly monitor for any unusual breast changes and to discuss any signs or symptoms with their doctor. Decisions regarding whether to keep, replace, or remove implants should be made in consultation with a clinician, taking into account individual symptoms, potential causes, and surgical risks.

They do not recommend preventive removal of implants due to surgery risks and encourage those experiencing symptoms to consult with a healthcare professional.

Nicolaidis recommended that individuals with symptoms seek a comprehensive medical evaluation. If no other reasons are identified, they can discuss the possibility that implants may be contributing to their issues and weigh their options with their healthcare providers.

He stopped implant placements in 2021 after concluding that the risks often outweighed the advantages, and now primarily focuses on implant removals. He noted that removal does not guarantee resolution of symptoms. Some patients he has treated for MS experienced only slight improvements, and individuals with diagnosed autoimmune conditions may still require medical treatment following explant surgery.

Elliott emphasized the importance of addressing implant-related symptoms seriously, while acknowledging that their causes are not completely understood. She encouraged patients to seek balanced, evidence-based information and monitor their health changes.

“The absence of complete answers does not mean that women’s experiences should be disregarded,” she stated.

Source

Share post:

spot_imgspot_img

Popular

More like this
Related

Saskatchewan Hits U.S. Alcohol with 50% Tariff in Trade Retaliation

Scott Moe, the Premier of Saskatchewan, has declared a...

Voyager 1 Nears Historic One Light-Day Milestone from Earth

Quirks and Quarks54:00Voyager approaches one light-day awayThis week on...

Noah Lyles Out of Ultimate Championship Due to Hamstring Injury

Olympic gold medalist Noah Lyles has concluded his season...

PQ Leader’s $130M Sovereignty Referendum Plan Faces Backlash

On Friday, Parti Québécois Leader Paul St-Pierre Plamondon faced...